Clinical outcomes in non‐small‐cell lung cancer patients with EGFR mutations: pooled analysis
L Paz‐Ares, D Soulières, I Melezínek… - Journal of cellular …, 2010 - Wiley Online Library
… potential for bias, it is possible that this bias would have also affected our pooled analysis.
No quality analysis of the included studies was undertaken; therefore, it is not possible to …
No quality analysis of the included studies was undertaken; therefore, it is not possible to …
Pooled analysis of clinical outcome for EGFR TKI‐treated patients with EGFR mutation‐positive NSCLC
L Paz‐Ares, D Soulieres, J Moecks… - Journal of Cellular …, 2014 - Wiley Online Library
… NSCLC provides an expanded dataset for analysis. This paper describes an … EGFR TKIs
in patients with EGFR mutation-positive NSCLC, and reports the results of a pooled analysis of …
in patients with EGFR mutation-positive NSCLC, and reports the results of a pooled analysis of …
Pooled analysis of the prospective trials of gefitinib monotherapy for EGFR-mutant non-small cell lung cancers
… who were genotyped for EGFR mutations and selected to receive gefitinib based on the
presence of an activating somatic mutation. We believe that our pooled analysis, combining 101 …
presence of an activating somatic mutation. We believe that our pooled analysis, combining 101 …
Pooled safety analysis of EGFR-TKI treatment for EGFR mutation-positive non-small cell lung cancer
M Takeda, I Okamoto, K Nakagawa - Lung Cancer, 2015 - Elsevier
… manifestation of ILD in unselected patients treated with EGFR-TKIs. Our pooled analysis of
EGFR-TKI treatment in EGFR mutation-positive NSCLC patients found that the frequency of all…
EGFR-TKI treatment in EGFR mutation-positive NSCLC patients found that the frequency of all…
… between the novel classification of lung adenocarcinoma subtypes and EGFR/KRAS mutation status: A systematic literature review and pooled-data analysis
L Jiang, M Mino-Kenudson, AC Roden, R Rosell… - European Journal of …, 2019 - Elsevier
… are pooled. In the present study, the pooled-data analysis showed that EGFR mutations … ,
we did not find any significant association between EGFR mutations and acinar, papillary and …
we did not find any significant association between EGFR mutations and acinar, papillary and …
[HTML][HTML] Neoadjuvant EGFR-TKI therapy for EGFR-mutant NSCLC: a systematic review and pooled analysis of five prospective clinical trials
L Sun, YJ Guo, J Song, YR Wang, SL Zhang… - Frontiers in …, 2021 - frontiersin.org
… Our pooled analysis indicated that neoadjuvant EGFR-TKI therapy may provide a feasible
treatment modality for patients with resectable or potentially resectable EGFR-mutant NSCLC, …
treatment modality for patients with resectable or potentially resectable EGFR-mutant NSCLC, …
EGFR-TKI therapy for patients with brain metastases from non-small-cell lung cancer: a pooled analysis of published data
Y Fan, X Xu, C Xie - OncoTargets and therapy, 2014 - Taylor & Francis
… In conclusion, our pooled analysis demonstrated that EGFR-TKIs are an … EGFR mutations.
Therefore, we emphasize that patients with NSCLC should be tested for EGFR mutations. The …
Therefore, we emphasize that patients with NSCLC should be tested for EGFR mutations. The …
… of gefitinib for non‐adenocarcinoma non‐small‐cell lung cancer patients harboring epidermal growth factor receptor mutations: A pooled analysis of published reports
T Shukuya, T Takahashi, R Kaira, A Ono… - Cancer …, 2011 - Wiley Online Library
… tumors harboring EGFR mutation were non-adenocarcinoma NSCLC. A pooled analysis was
… non-adenocarcinoma NSCLC patients harboring EGFR mutations. A systematic search of …
… non-adenocarcinoma NSCLC patients harboring EGFR mutations. A systematic search of …
Metastatic site location influences the diagnostic accuracy of ctDNA EGFR-mutation testing in NSCLC patients: a pooled analysis
… the ability to identify EGFR mutations. Objective: This pooled analysis aims to evaluate the …
and the sensitivity of ctDNA analysis in detecting EGFR mutations in NSCLC patients. Methods…
and the sensitivity of ctDNA analysis in detecting EGFR mutations in NSCLC patients. Methods…
[HTML][HTML] … lung adenocarcinoma with transformation to small cell lung cancer after EGFR tyrosine kinase inhibitors resistance: A systematic review and pooled analysis
J Xu, L Xu, B Wang, W Kong, Y Chen, Z Yu - Frontiers in Oncology, 2022 - frontiersin.org
… Our pooled analysis shows that the realization of SCLC phenotype mostly takes more
than 1 year, and the prognosis of patients after SCLC diagnosis is worse than primary SCLC. …
than 1 year, and the prognosis of patients after SCLC diagnosis is worse than primary SCLC. …
相关搜索
- egfr mutations cell lung cancer
- egfr mutation status
- egfr mutations nsclc patients
- egfr mutations tyrosine kinase inhibitors
- pooled analysis systematic review
- egfr mutations in patients subset analysis
- pooled analysis egfr tki treated patients
- egfr mutations gene expression analysis
- egfr mutation detection real world analysis
- pooled analysis growth factor receptor mutations
- compound egfr mutations
- correlation of egfr mutation
- pooled analysis of published data
- egfr mutations growth factor receptor
- efficacy analysis complex egfr mutations
- egfr mutations combined survival analysis